Pharma: Other News To Note

March 2013
BioWorld Today;3/ 7/2013, Vol. 24 Issue 44, p7
The article offers world news briefs related to the pharmaceutical industry which include the license distribution agreement signed by Grunenthal Group and EthyPharm SA, the $45 million settlement paid by Par Pharmaceutical Cos. Inc., and the agreement signed by Roche AG and BioLamina AB.


Related Articles

  • Roche.  // Formulary;Oct2000 Resource Guide, Vol. 35 Issue 10, p83 

    Features the Roche Holding Ltd., a pharmaceutical manufacturer. Focus of its international research and development efforts; Total shares at the biotechnology company, Genentech Inc.; Pharmaceutical products that have received approval from the United States Food and Drug Administration.

  • Global Report.  // Pharmaceutical Representative;Nov2011, Vol. 41 Issue 11, p10 

    The article offers information related to the pharmaceutical industry such as the end of the deal to supply drugs between Roche and the state-funded hospitals in Greece, and the adoption by the European Commission (EC) of the revised proposals on supplying prescription-only drugs to the public.

  • It's Roche vs Schering-Plough for hepatitis-C market.  // Medical Marketing & Media;Nov2002, Vol. 37 Issue 11, p10 

    Reports on Roche AG's receipt of U.S. Food and Drug Administration approval for Pegasys, a drug for treatment of hepatitis C. Marketing program; Competition with PEG-Intron from Schering-Plough.

  • Healthy combo.  // Business News New Jersey;10/02/96, Vol. 9 Issue 20, p3 

    Focuses on the business partnership formed between Bayer AG's Consumer Care Division and Roche Holding AG to market a batch of the firms' over-the-counter drugs.

  • Brazil, Roche set drug price.  // Medical Marketing & Media;Oct2001, Vol. 36 Issue 10, p24 

    Reports the agreement of Roche to meet the request of the Brazilian government to reduce the cost of Viracept.

  • Top 5 Bio/Pharma Deals This Year.  // BioWorld Insight;10/25/2010, Vol. 18 Issue 43, p7 

    A table is presented that depicts the top five biotechnology and pharmaceutical company deals of 2010 including Rigel Corp., AstraZeneca PLC, and Roche Holdings AG.

  • Roche moves ad deal to JWT and gears for China.  // Media: Asia's Media & Marketing Newspaper;10/3/2003, p3 

    Swiss pharmaceutical company F. Hoffman-La Roche AG is believed to be looking at shifting its regional account to J. Walter Thompson. The shift comes at a time when Roche is looking at stepping up its marketing investment in the region, particularly in China's emerging pharmaceutical market....

  • Ultra-Fast Track Approach, Combined With An Integrated And Highly Motivated Project Team Leads To Award Recognition. Auerbach, Michael // Pharmaceutical Processing;Sep2008, Vol. 23 Issue 9, p12 

    The article announces that F. Hoffmann-La Roche's BIO IV facility has received the Facility of the Year Award (POYA) sponsored by International Society for Pharmacoepidemiology (ISPE), INTERPHEX and "Pharmaceutical Processing" magazine.

  • Drug Wars. Feuer, Jack // Adweek Midwest Edition;08/28/2000, Vol. 41 Issue 35, p9 

    Provides information on direct-to-consumer pharmaceutical media planning and buying consolidation reviews. Companies that conducted advertising reviews; Information on Roche reviews for Xenical and the flu pill Tamiflu.

  • Roche Mulls $130 MM Expansion. Thurston, Charles // Chemical Market Reporter;11/15/99, Vol. 256 Issue 20, p18 

    Reports on the expansion considered by Roche that would include capacity in Argentina, Brazil and Mexico. Amount of investment that would be earmarked for Brazil, for Argentina and for Mexico; Other multinationals that have invested in Brazil's pharmaceutical sector.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics